Summary
Better drugs are one of the most efficient and sustainable ways to improve health care, a key strategic orientation in Horizon Europe.
New drug modalities such as macrocycles are expected to be a key enabling technology for this strategic perspective. The goal of MC4DD is to train the next generation of European medicinal chemists in a multidisciplinary environment to promote European drug discovery competitiveness, directly by advancing knowhow on macrocycles and long-term via the skills carried on by the researchers trained in the doctoral network.
New drug modalities such as macrocycles are expected to be a key enabling technology for this strategic perspective. The goal of MC4DD is to train the next generation of European medicinal chemists in a multidisciplinary environment to promote European drug discovery competitiveness, directly by advancing knowhow on macrocycles and long-term via the skills carried on by the researchers trained in the doctoral network.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101168916 |
| Start date: | 01-11-2024 |
| End date: | 31-10-2028 |
| Total budget - Public funding: | - 3 270 780,00 Euro |
Cordis data
Original description
Better drugs are one of the most efficient and sustainable ways to improve health care, a key strategic orientation in Horizon Europe.New drug modalities such as macrocycles are expected to be a key enabling technology for this strategic perspective. The goal of MC4DD is to train the next generation of European medicinal chemists in a multidisciplinary environment to promote European drug discovery competitiveness, directly by advancing knowhow on macrocycles and long-term via the skills carried on by the researchers trained in the doctoral network.
Status
SIGNEDCall topic
HORIZON-MSCA-2023-DN-01-01Update Date
15-09-2024
Images
No images available.
Geographical location(s)
Search
Organisations
-
| TECHNISCHE UNIVERSITAT DARMSTADT (Coördinator)
-
| ABBVIE DEUTSCHLAND GMBH & CO KG
-
| ANALYTICON DISCOVERY GMBH
-
| ASTRAZENECA AB
-
| Bayer AG
-
| ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
-
| EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
-
| ENAMINE GERMANY GMBH
-
| F. HOFFMANN-LA ROCHE AG
-
| FIDELTA DOO ZA ISTRAZIVANJE I RAZVOJ
-
| JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN
-
| NOVO NORDISK A/S
-
| SANOFI-AVENTIS DEUTSCHLAND GMBH
-
| THE UNIVERSITY OF CAMBRIDGE
-
| UKRORGSYNTEZ